Generation of mouse polyclonal and human monoclonal antibodies against Bacillus anthracis toxin

Drugs under Experimental and Clinical Research

Volumn 31, Issue 2, 2005, Pages 35-43

  Huber, M ^a,c   Vor Dem Esche, U ^a   Grunow, R ^b   Bessler, W G ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b BUNDESWEHR INSTITUTE OF MICROBIOLOGY   (Germany)

^c Institute of Biochemistry and Molecular Biology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX TOXIN; ANTHRAX VACCINE; LIPOPEPTIDE; MACROGOL; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; ANTITOXIN; BACTERIAL ANTIGEN; BACTERIAL TOXIN; FREUND ADJUVANT; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ANTHRAX; ARTICLE; B LYMPHOCYTE; BACILLUS ANTHRACIS; CELL IMMORTALIZATION; CELL LINE; CONTROLLED STUDY; IMMUNIZATION; IN VITRO STUDY; LETHAL GENE; MACROPHAGE; MOLECULAR CLONING; MOUSE; MYELOMA; NONHUMAN; PERIPHERAL LYMPHOCYTE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HYBRIDOMA; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; SERODIAGNOSIS; WESTERN BLOTTING;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; ANTITOXINS; BACILLUS ANTHRACIS; BACTERIAL TOXINS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FREUND'S ADJUVANT; HUMANS; HYBRIDOMAS; IMMUNOGLOBULIN G; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; RECOMBINANT PROTEINS;

EID: 23244444155     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ross J.M. The pathogenesis of anthrax following the administration of spores by respiratory route. J. Path. Bact., 73, 483, 1957.
2. Jones W.I. Jr., Klein F., Lincoln R.E., Walker J.S., Mahlandt B.G., Dobbs J.P. Antibiotic treatment of anthrax infection in mice. J. Bacteriol., 94(3), 609, 1967.
3. Altboum Z., Gozes Y., Barnea A., Pass A., White M., Kobiler D. Postexposure prophylaxis against anthrax: Evaluation of various treatment regimens in intranasally infected guinea pigs. Infect. Immun., 70(11), 6231, 2002.
4. Friedlander A.M., Welkos S.L., Pitt M.L., et al. Postexposure prophylaxis against experimental inhalation anthrax. J. Infect. Dis., 167(5), 1239, 1993.
5. Bradley K.A., Mogridge J., Mourez M., Collier R.J., Young J.A. Identification of the cellular receptor for anthrax toxin. Nature, 414, 225, 2001.
6. Pannifer A.D., Wong T.Y., Schwarzenbacher R., et al. Crystal structure of the anthrax lethal factor. Nature, 414, 229, 2001.
7. Robertson D.L., Tippetts M.T., Leppla S.H. Nucleotide sequence of the Bacillus anthracis edema factor gene (cya): A calmodulin-dependent adenylate cyclase. Gene, 73(2), 363, 1988.
8. Duesbery N.S., Webb C.P., Leppla S.H., et al. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science, 280, 734, 1998.
9. Flick-Smith H.C., Walker N.J., Gibson P., et al. A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection. Infect. Immun., 70, 1653, 2002.
10. Pezard C., Weber M., Sirard J.C., Berche P., Mock M. Protective immunity induced by Bacillus anthracis toxin-deficient strains. Infect. Immun., 63(4), 1369, 1995.
11. Gaur R., Gupta P.K., Banerjea A.C., Singh Y. Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin. Vaccine, 20, 2836, 2002.
12. Varughese M., Teixeira A.V., Liu S., Leppla S.H. Identification of a receptor-binding region within Domain 4 of the protective antigen component of anthrax toxin. Infect. Immun., 67(4), 1860, 1999.
13. Little S.F., Ivins B.E., Fellows P.F., Pitt M.L., Norris S.L., Andrews G.P. Defining a serological correlate of protection in rabbits fora recombinant anthrax vaccine. Vaccine, 22(3-4), 422, 2004.
14. Beedham R.J., Turnbull P.C., Williamson E.D. Passive transfer of protection against Bacillus anthracis infection in a murine model. Vaccine, 19(31), 4409, 2001.
15. Pitt M.L., Little S.F., Ivins B.E., et al. In vitro correlate of immunity in a rabbit model of inhalational anthrax. Vaccine, 19(32), 4768, 2001.
16. Reuveny S., White M.D., Adar Y.Y., et al. Search for correlates of protective immunity conferred by anthrax vaccine. Infect. Immun., 69(5), 2888, 2001.
17. Little S.F., Ivins B.E., Fellows P.F., Friedlander A.M. Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs. Infect. Immun., 65(12), 5171, 1997.
18. Kobiler D., Gozes Y., Rosenberg H., Marcus D., Reuveny S., Altboum Z. Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization. Infect. Immun., 70(2), 544, 2002.
19. Bessler W.G., Jung G. Synthetic lipopeptides as novel adjuvants. Res. Immunol., 143, 548, 1992.
20. Bessler W.G., Baier W., vor dem Esche U., et al. Bacterial lipopeptides constitute efficient novel immunogens and adjuvants in parenteral and oral immunization. Behring Institute Research Communications, 98, 390, 1997.
21. Baier W., Masihi N., Huber M., Hoffmann P., Bessler W.G. Lipopeptides as immunoadjuvants and immunostimulants in mucosal immunization. Immunobiol., 201, 391, 1999/2000.
22. 4 constitutes an adjuvant in parenteral and oral immunization. Vaccine Res., 6, 127, 1997.
23. Hoffmann P., Jiménez-Díaz M., Weckesser J., Bessler W.G. Murine bone marrow-derived macrophages constitute feeder cells for human B cell hybridomas. J. Immunol. Meth., 196, 85, 1996.
24. Ayoub M., Lallouette P., Sütterlin W., Bessler W.G., Huber M., Mittenbühler K. Modulation of the Th1/Th2 bias by an immunoglobulin histamine complex in the ovalbumin allergy mouse model. Internat. Immunopharmacol., 460, 1, 2003.
25. Huber M., Baier W., Bessler W.G., Heinevetter L. Modulation of the Th1/Th2 bias by lipopeptide or saponin adjuvants in orally immunized mice. Immunobiol., 205, 61, 2002.
26. Kreutz M., Ackermann U., Hauschildt S., Krause S.W., Riedel D., Bessler W.G. A comparative analysis of cytokine production and tolerance induction by bacterial lipopeptides, lipopolysaccharides, and Staphylococcus aureus in human monocytes. Immunol., 92, 396, 1997.
27. Pfannes S.D.C., Müller B., Körner S., Bessler W.G., Hoffmann P. Induction of soluble antitumoral mediators by synthetic analogues of bacterial lipoprotein in bone marrow-derived macrophages from LPS-responder and -nonresponder mice. J. Leukoc. Biol., 69, 590, 2001.
28. Mohamed N., Li J., Ferreira C.S., et al. Enhancement of anthrax lethal toxin cytotoxicity: A subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages. Infect. Immun., 72, 3276, 2004.